Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Scientific Reports
|
February 21, 2017
Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach
Valeriy Domenyuk, Zhenyu Zhong, Adam Stark, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 2, 2022
FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies
Carlotta Antoniotti, Marco M Germani, Daniele Rossini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2021
Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study
Carlotta Antoniotti, W Michael Korn, Federica Marmorino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2022
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
Philip A Philip, Ibrahim Azar, Joanne Xiu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2023
Multi-omic characterization reveals a distinct molecular landscape in young-onset pancreatic cancer
Ifeanyichukwu Ogobuiro, Yasmine Baca, Jennifer R Ribeiro, et al.
JCO Precision Oncology
|
January 21, 2026
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry
Michiko Nagamine, Takao Fujisawa, Naoya Sakamoto, et al.
Nature Cancer
|
March 26, 2024
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers
Maishara Muquith, Magdalena Espinoza, Andrew Elliott, et al.
JCO Precision Oncology
|
November 9, 2023
Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer
Ifeanyichukwu Ogobuiro, Yasmine Baca, Jennifer R Ribeiro, et al.
Neuro-Oncology Advances
|
January 11, 2021
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram
Sherise D Ferguson, Tiffany R Hodges, Nazanin K Majd, et al.
Journal of the National Cancer Institute
|
September 1, 2021
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications
Roberto Moretto, Andrew Elliott, Jian Zhang, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Scientific Reports
|
February 21, 2017
Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach
Valeriy Domenyuk, Zhenyu Zhong, Adam Stark, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 2, 2022
FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies
Carlotta Antoniotti, Marco M Germani, Daniele Rossini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2021
Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study
Carlotta Antoniotti, W Michael Korn, Federica Marmorino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2022
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
Philip A Philip, Ibrahim Azar, Joanne Xiu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2023
Multi-omic characterization reveals a distinct molecular landscape in young-onset pancreatic cancer
Ifeanyichukwu Ogobuiro, Yasmine Baca, Jennifer R Ribeiro, et al.
JCO Precision Oncology
|
January 21, 2026
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry
Michiko Nagamine, Takao Fujisawa, Naoya Sakamoto, et al.
Nature Cancer
|
March 26, 2024
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers
Maishara Muquith, Magdalena Espinoza, Andrew Elliott, et al.
JCO Precision Oncology
|
November 9, 2023
Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer
Ifeanyichukwu Ogobuiro, Yasmine Baca, Jennifer R Ribeiro, et al.
Neuro-Oncology Advances
|
January 11, 2021
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram
Sherise D Ferguson, Tiffany R Hodges, Nazanin K Majd, et al.
Journal of the National Cancer Institute
|
September 1, 2021
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications
Roberto Moretto, Andrew Elliott, Jian Zhang, et al.
Page
of 9